Sort
8,912 grants matching “sars cov 2”
Host genetic determinants regulating susceptibility/resistance to SARS-CoV-2
$205,810Kui Li · University Of Tennessee Health Sci Ctr · R21 · FY2022 · AI
Using wastewater surveillance data to study SARS-CoV-2 dynamics and predict COVID-19 outcomes
$205,625Wan Yang · Columbia University Health Sciences · R21 · FY2024 · AI
The "olfactosome" as a biomolecular condensate
$205,625Stavros Lomvardas · Columbia University Health Sciences · R21 · FY2023 · DA
Changes in the public health burden of tobacco use during the COVID-19 pandemic: the C4R Study
$205,625Pallavi P Balte · Columbia University Health Sciences · R21 · FY2023 · HL
Origin and host adaptation of the novel canine coronavirus (CCoV-HuPn-2018) isolated from a human pneumonia patient
$205,587Anastasia Nickolaevna Vlasova · Ohio State University · R21 · FY2023 · AI
Administrative Core
$205,428Monica Kraft · University Of Arizona · U19 · FY2023 · AI
Environmental Factors Predicting Risk of Severe COVID Infection
$205,000Elizabeth Anne Regan · National Jewish Health · R21 · FY2022 · ES
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19
$205,000Theodoros Kelesidis · Ut Southwestern Medical Center · R21 · FY2025 · AI
Understand the molecular mechanism of age-associated decline in antiviral CD8 T cell immunity
$205,000Tuoqi Wu · Ut Southwestern Medical Center · R21 · FY2023 · AG
Pre-Analytic Factors affecting Molecular tests for Congenital Syphilis
$205,000Jeffrey Sorelle · Ut Southwestern Medical Center · R21 · FY2025 · AI
COVID19 vaccine hesitancy among perinatal women at risk for health disparities
$204,991Cynthia L Battle · Butler Hospital (Providence, Ri) · R21 · FY2023 · HD
Investigation of sarbecovirus exposure patterns and development of pan-SARS-CoV-2 neutralizing antibody responses in high-risk cohorts in Myanmar
$204,874Tierra Smiley Evans · University Of California At Davis · R21 · FY2023 · AI
Novel TLR-4 Agonists as Vaccine Adjuvants
$204,860Alan Thomas Johnson · Hawaii Biotech, Inc. · R43 · FY2024 · AI
Project 3- Access Study
$204,764Kimberly Ann Chapman · Baylor College Of Medicine · U54 · FY2025 · HD
Mechanisms of immunopathology of COVID-19/ARDS, and strategies to mitigate detrimental inflammatory responses
$204,714Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
A muco-penetrating biomaterial-based subunit vaccine for programming protective immune responses to SARS-CoV-2
$204,688David Scott Wilson · Johns Hopkins University · R21 · FY2022 · EB
The first polymeric opioid conjugate vaccine
$204,688David Scott Wilson · Johns Hopkins University · R21 · FY2021 · DA
mRNA vaccine responses in PLWH
$204,688Joel N Blankson · Johns Hopkins University · R21 · FY2023 · AI
Profiling the immune response to convalescent plasma therapy during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
$204,688Jay H. Bream · Johns Hopkins University · R21 · FY2022 · AI
A muco-penetrating biomaterial-based subunit vaccine for programming protective immune responses to SARS-CoV-2
$204,688David Scott Wilson · Johns Hopkins University · R21 · FY2021 · EB
Scientific Project 2: HIV AIDS Defining molecular signatures in humans following vaccination that can inform pathways to protective immunity against HIV-1 infection
$204,536Margaret Juliana McElrath · Seattle Children'S Hospital · U19 · FY2022 · AI
Investigating the molecular mechanisms of membrane remodeling by coronaviruses
$204,427Michael Joseph Ragusa · Dartmouth College · UH2 · FY2023 · AI
Roles of human surfactant collectin variants in the susceptibility of COVID-19
$203,750Guirong Wang · Upstate Medical University · R21 · FY2023 · AI
Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation
$203,611Trevor Bc Bedford · Fred Hutchinson Cancer Research Center · R35 · FY2021 · GM
SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs
$203,580Mary Catherine Cambou · University Of California Los Angeles · K23 · FY2025 · AI